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ABSTRACT 
 A study investigated the use of Anti-Mullerian hormone (AMH) and/or follicle counts as 
a predictor of subsequent superovulatory response and embryo production in 79 beef cows. 
Before initiation of superovulation, ultrasonography was used to scan the ovaries of each donor 
cow to record the number of 3 to 5 mm follicles present, and a blood sample was collected for 
measure of serum AMH.  At the time of embryo collection, the ovaries of donor cows were 
palpated to estimate the number of corpora lutea (CL) present on each ovary.  Recovered 
embryos were evaluated for stage of development and morphological quality.  Across cows, 
serum AMH ranged from 0.013 to 0.898 ng/mL, with a mean of 0.293 ng/mL.  The distribution 
of AMH concentrations was divided into quartiles (AMH Q1 through Q4, with Q1 the lowest 
and Q4 the highest, ng/mL) for analysis.  Donor cows in AMH Q4 had a greater (P < 0.001) 
number of 3 to 5 mm follicles at the start of superovulation than did donors in either Q1 or Q2.  
At embryo collection, cows in AMH Q3 and 4 had more (P < 0.001) palpable CL than cows in 
AMH Q1.  The mean number of embryos recovered from donor cows in AMH Q4 was greater (P 
< 0.001) than those recovered from cows in either AMH Q1 or 2, but similar to that of AMH Q3.  
The percentage of recovered embryos classified as transferrable, degenerate or unfertilized were 
similar (P  0.275) across AMH quartiles.  Analysis indicated that AMH was positively 
correlated (P < 0.001) with mean follicles (r = 0.458), CL (r = 0.452) and embryos recovered (r = 
0.430).  In order to determine if follicle counts at the start of superovulation might also be 
predictive of subsequent superovulatory response, the distribution of follicle counts were divided 
into quartiles (F Q1 through Q4, with Q1 the lowest and Q4 the highest) for analysis.  Donor 
cows with higher follicle counts (F Q3 and 4) at the start of superovulation had more (P < 0.001) 
palpable CL at embryo collection than donor cows in F Q1 or 2.  More (P < 0.001) embryos were 
 
 
recovered from cows with the highest follicle counts (F Q4) as compared with cows having 
lower (F Q1 and 2) follicle counts.  The percentage of transferable embryos and unfertilized ova 
were similar (P  0.688) across follicle count quartiles.  As was noted for AMH, mean number of 
follicles at the start of superovulation was positively correlated (P < 0.001) with mean CL (r = 
0.556) and mean embryos (r = 0.423) but not percentage of viable or degenerate embryos, or 
unfertilized oocytes (P  0.153).  In conclusion, results confirm that relative AMH concentration 
was positively correlated with number of small antral follicles in the ovaries of cows and might 
be used to either predict superovulatory response or possibly adjust superovulatory regimen to 
improve superovulatory response.  Antral follicle counts at the initiation of superovulatory 
treatments might be a more practical alternative to AMH for predicting superovulatory response.  
Further study is needed to determine the effectiveness of using either AMH concentration or 
follicle counts to adjust superovulatory regimens for improved response. 
 
 
 
 
 
 
 
 
 
 
 
 
 
ACKNOWLEDGEMENTS 
In completing a degree such as this, I personally have many people to not only thank but 
acknowledge.  I have listed here these people not necessarily in any particular order, but rather in 
order of which these people prolonged me towards reaching my full potential as well as, played 
an impact on me or my career: 
 First, I would like to take this opportunity to thank my family for supporting me 
in all that I do, whether it be personally, academically, or otherwise, and being my 
venting board to allow me the opportunity and inspiration to make it through it 
all: Grand-mommy (Inez Howard), Papaw and Granny (Lovell Mayse and Wanda 
Bang), my Aunts (Billie Jo Howard, Sandy Howard, Hannah Mayse and Jennifer 
Mayse,), my Uncles (Larry Mayse, Phillip Mayse and Richard Mayse), my mom 
(Lisa Williams), my brothers (Brandon and Paden Center), my beautiful baby 
sister (Alyssa Dale Williams), my sister-in-laws (Alex Tye and Stacy Sheets), my 
nephew (Gauge Tye) and my beautiful niece (Aydriona Rose Leigh Sheets).   
 To Dr. Troy Wistuba, who funded my assistantship through Novus International 
my first year of Graduate school and also served as my advisor while pursuing my 
undergraduate degree at Morehead State University. 
 To my fellow graduate students (Elizabeth Backes, Kelsey Basinger, Carley 
Calico, Jessica Clark, Dan Cook, Amanda Davis, Tom Devine, Chester Greub, 
Matt Fryer, Cameron Jernigan, Haley Jernigan, Casey Orr, Matheus Palhano, 
Tony Ryan, Brandon Smith and Ashley Young) for their assistance, guidance, and 
friendship throughout the conduction of my research. 
 
 
 To the Culp family: Muzzy and Papa (Sandra and Kenny Culp Jr.), Dr. Ken Culp 
III, Nancy Culp, Kelsey Culp, Laurel Culp, Kendell Culp, Tammy Culp, Kayla 
Culp, and Brandon Culp, for providing me the opportunity to work with their 
cattle where AI and embryo transfer practices are used, which ultimately led me 
to find my passion within the agriculture industry and inspired me to become an 
embryologist. 
 To Sandra and Kenny Culp Jr. for allowing me, to live with them in Rensselaer, 
Indiana throughout the conduction of my research project, and treating me as if I 
was their own grandson.  I will forever be great-full for all their support and 
guidance along this journey.  
 To a very special friend Shelby Rae Toy, who supported me throughout the 
conduction on my research project in Indiana with Donor Care and my last year of 
graduate school at the University of Arkansas.  If not for her and her believing in 
me more than I believed in myself completing this degree would have never been 
possible.  I will forever be thankful for meeting such an inspirational young 
woman.  
 To Dr. Dave Dixon, owner of Donor Care for funding and helping conduct my 
research project and pushing me to reach my full potential. 
 To Drs., Charles Looney and Scott Jaques for analyzing the Anti-Mullerian 
hormone concentrations in my research project.   
  To my committee members, Drs., Michael Looper, Charles Rosenkrans, and Troy 
Wistuba, for their support and willingness to serve as advisors to my master’s 
studies. 
 
 
 And last, but certainly not least, Dr. Rick Rorie, for taking a long shot chance on 
me and accepting me into his program and putting his trust and faith in me while 
he continued to push me to better myself both professionally and personally and 
never allowing me to give up.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DEDICATION 
I would like to dedicate this thesis to four people, all of whom have played very 
influential roles throughout my life.  Without any one of these people, receiving or let alone 
completing a degree such as this would have never been possible.  These four very special 
individuals include: my grandfather, Lovell Mayse, grandmother, Wanda Bang, mother Lisa 
Williams and mentor Dr. Ken Culp III.  Having been raised primarily by my grandfather on a 
small family farm in eastern Kentucky I gained a great deal of appreciation for agriculture at a 
very young age.  His interest in animal agriculture and the lifestyle with which it came are the 
primary reasons that I decided to pursue a career in Animal Science.  My grandmother worked 
for fourteen years at Morehead State University in the Agricultural Sciences Dean’s office and 
she too has always had a passion for agriculture, being raised on a small 300 acre farm in eastern 
Kentucky.  My mother always supported me in all my endeavors and showed me what a true 
mother’s love could do if you believed in yourself.  These three individuals taught me the true 
values in life and that anything is possible if you believe in yourself.  Dr. Ken Culp III, came into 
my life when I was a junior pursuing my BS degree from Morehead State University.  Through 
his mentoring and leadership I found my passion within the Agricultural Industry which led me 
to pursue a MS degree in Reproductive Physiology.  He continues to push and support me every 
day to reach my full potential as if I were his own son.  I will forever be grateful for all your 
support and help.     
By wisdom a house is built and by understanding it is established.  By knowledge the rooms are 
filled with precious and pleasant riches.  A wise man is full of strengths, and a man of knowledge 
enhances his might, for by wise guidance you can wage war and in abundance of counselors 
there is victory.  Proverbs 24: 3-6 
 
 
TABLE OF CONTENTS 
CHAPTER 1: LITERATURE REVIEW ................................................................................... 1 
Sexual Differentiation and Discovery of Anti-Mullerian Hormone ........................................... 1 
Role of Anti-Mullerian Hormone in Females ............................................................................. 2 
Anti-Mullerian Hormone as a Predictor of Follicular Population and Fertility .......................... 3 
Superovulation and embryo transfer ........................................................................................... 6 
Conclusion ................................................................................................................................... 9 
References ................................................................................................................................. 11 
CHAPTER 2: ANTI-MULLERIAN HORMONE AS A PREDICTIVE ENDOCRINE 
MARKER FOR SUPEROVULATORY RESPONSE AND EMBRYO PRODUCTION IN 
BEEF CATTLE ........................................................................................................................... 15 
Abstract ..................................................................................................................................... 15 
Introduction ............................................................................................................................... 17 
Materials and Methods .............................................................................................................. 18 
Animals and Superovulatory Treatments. ............................................................................. 18 
Ultrasonography and Blood Collection. ................................................................................ 19 
Embryo Recovery and Evaluation. ........................................................................................ 20 
Analysis of Serum Anti-Mullerian Hormone. ....................................................................... 20 
Statistical Analysis. ............................................................................................................... 20 
Results ....................................................................................................................................... 21 
Measure of AMH and its predictive value for superovulatory response. .............................. 22 
Predictive value of follicle number for superovulatory response. ......................................... 22 
Repeatability within donors. .................................................................................................. 23 
Discussion ................................................................................................................................. 24 
References ................................................................................................................................. 29 
Table 1. Quartile categorization of AMH concentrations as predictor of superovulatory 
outcomes. ............................................................................................................................... 32 
Table 2. Correlations between AMH, follicle counts, and embryo production of             
superovulated donor cows. .................................................................................................... 33 
 
 
Table 3. Quartile categorization of follicle counts as a predictor of superovulatory response 
and embryo production. ......................................................................................................... 34 
Table 4.  Repeatability of embryo donors for AMH, follicle and corpus luteum counts and 
embryo production. ................................................................................................................ 35 
CHAPTER 3: CONCLUSION................................................................................................... 36 
 
 LIST OF ABBREVIATIONS 
All abbreviations in this thesis are also defined in the text. 
AETA  American embryo transfer association 
AFC  antral follicle count 
AMH  anti-mullerian hormone 
ART  assisted reproductive technology 
BCS  body condition score 
CIDR  controlled internal drug release 
CL  corpus luteum 
ET  embryo transfer 
FSH  follicle stimulating hormone 
GnRH  gonadotropin-releasing hormone 
IETS  International embryo transfer society  
IVF  in vitro fertilization  
LH  luteinizing hormone  
MIS  mullerian inhibiting substance 
MOET  multiple ovulation and embryo transfer 
PRID  progesterone-releasing intravaginal device 
SRY  sex-determining region Y 
TDF  testis-determining factor 
1 
 
CHAPTER 1: LITERATURE REVIEW 
Sexual Differentiation and Discovery of Anti-Mullerian Hormone 
 German anatomist and physiologist, Johanness Muller (1801-1858) is credited with the 
first description of the Mullerian ducts, the anlagen of the uterus, oviducts and anterior vagina.  
The Wolffian ducts (named for German anatomist Caspar F. Wolff; 1733-1794) are male 
counterparts of the Mullerian ducts and differentiate into the vas deferens, epididymides and 
seminal vesicles (Teixeira et al., 2001).  In females, the Wolffian ducts degenerate, giving rise 
only to the Mullerian ducts whereas in males, two processes must occur.  First the Wolffian ducts 
must be stimulated and maintained to differentiate into the male reproductive tract by 
testosterone produced by Leydig cells in the testes.  Secondly, the Mullerian ducts regress due to 
the action of Anti-Mullerian hormone (AMH; Munsterberg and Lovell-Badge, 1991).  
 Anti-Mullerian hormone is a homodimeric disulfide-linked glycoprotein in the 
transforming growth factor beta family, with a molecular weight of 140 kDa (La Marca and 
Volpe, 2006).  Alfred Jost is credited for discovering AMH in the 1940s.  By performing in vivo 
embryonic experiments in rabbits, Jost demonstrated the existence of what he called Mullerian 
"hormone inhibitrice" or “Mullerian inhibitor” (Teixeira et al., 2001).  Anti-Mullerian hormone 
is responsible for establishing embryonic sexual dimorphism based on presence or absence of the 
testis-determining factor (TDF), also known as sex-determining region Y (SRY) (Tüttelmann et 
al., 2009).  In the presence of a Y chromosome, the genital ridge will arise on the mesonephros 
and a testis will develop due to the action of the TDF.  Leydig cells of the developing testes 
produce testosterone to maintain and develop the Wolffian ducts while AMH produced by 
Sertoli cells causes regression of the Mullerian ducts.  If the Y chromosome is absent, a default 
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pathway is followed resulting in development of an ovary (Munsterberg and Lovell-Badge, 
1991).  
 In cattle, freemartins are an example of abnormal sexual differentiation that occurs when 
a female is born twin to a male calf.  During early gestation, the placentae of developing male 
and female fetuses fuse, resulting in common fetal circulation.  Testosterone and AMH produced 
by the developing male testes enters female circulation to inhibit female reproductive tract 
development.  Freemartins are first recognizable about 49 days of gestation, when the upper part 
of the Mullerian ducts regress and the presumptive ovaries stop growing (Jost et al., 1972).  After 
birth, the female ovaries are often stunted and contain sterile seminiferous tubules (Jost et al., 
1972).  Portions of the Wolffian ducts, including the seminal vesicles and epididymis are present 
but no change is noted in the external genitalia (Jost et al., 1972).  
Role of Anti-Mullerian Hormone in Females 
 While the role of AMH in male sexual differentiation is well known, more recent studies 
have demonstrated that granulosa cells within follicles in the ovaries of females also produce 
AMH.  In the male, a six week old fetal testis has no AMH expression, but AMH is expressed by 
eight and one-half weeks of development (Rajpert-De Meyts et al., 1999).  Expression of AMH 
in the male increases after birth, then gradually declines until puberty.  In the female, AMH 
expression is not detected in granulosa cells of pre-antral follicles in fetal ovaries until 36 weeks 
gestation (Rajpert-De Meyts et al., 1999).  Production of AMH by granulosa cells continues until 
the end of ovarian activity at reproductive senescence (Josso et al., 2001).  While antral follicles 
2 to 5 mm in diameter produce more AMH due to high granulosa cell numbers, smaller follicles 
also contribute to serum AMH concentrations based on their larger numbers within ovaries (Van 
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Rooij et al., 2002).  Therefore, the relative contribution of the different follicle stages to the final 
serum AMH concentration is unclear. 
 Anti-Mullerian hormone functions to regulate the recruitment of primordial follicles into 
the pool of growing follicles (i.e, folliculogenesis) and regulate the responsiveness of follicles to 
follicle stimulating hormone (FSH; Visser et al., 2006).  Primordial follicles (resting stage) are 
formed within the ovaries of developing females during the first trimester of gestation.  At birth, 
the number of follicles present in the ovaries of heifer calves is reported to range from 10,000 to 
350,000 (Erickson, 1966).  Studies utilizing AMH-deficient mice as a model show that such 
mice are fertile, but delete the number of primordial follicles in their ovaries earlier in life than 
control mice (Durlinger et al., 1999).  Anti-Mullerian hormone limits the number of primordial 
follicles entering folliculogenesis at any given time by reducing their responsiveness to FSH 
(Visser et al., 2006).  As antral-stage follicles grow beyond 4 to 5 mm in diameter, their AMH 
production declines, resulting in increased responsiveness to FSH.  The antral follicle within the 
pool of growing follicles with greatest responsiveness to FSH is likely the one selected to 
become the dominant follicle. 
Anti-Mullerian Hormone as a Predictor of Follicular Population and Fertility  
 Anti-Mullerian hormone is highly correlated with the total number of healthy follicles 
within the ovaries (Visser et al., 2006).  If AMH is to be used to characterize the follicular 
population within ovaries, the question arises as to when and how often AMH should be 
measured to accurately reflect that follicular population.  Ireland et al. (2008) used 
ultrasonography to characterize beef heifers as having low, intermediate or high antral follicle 
counts, then measured AMH daily, from day 6 of the estrous cycle through day 2 of the 
subsequent cycle.  Although AMH varied somewhat by day of estrous cycle, all measures of 
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AMH correctly characterized heifers into low, intermediate and high categories, regardless of 
day of the cycle when AMH was measured.  Therefore, a single measurement of AMH 
concentration in serum can be used to determine the size of the ovarian reserve of follicles.  After 
measure of AMH from day 6 through day 2 of the subsequent estrous cycle, Ireland et al. (2008) 
surgically removed one ovary from each heifer characterized as having either high and low antral 
follicle counts for further histological analysis.  Heifers characterized as having low follicle 
counts were found to have 60% smaller ovaries and 80% fewer morphologically healthy follicles 
and oocytes, suggesting a link between follicle number and fertility.  
Low concentrations of progesterone in circulation are associated with higher embryonic 
mortality in cattle (Mann and Lamming, 1999).  Both beef and dairy cows characterized as 
having low antral follicle counts also have progesterone concentrations that are 40 to 50% lower 
during the luteal phase of the estrous cycle than similar cows having high antral follicular counts 
(Jimenez-Krassel et al., 2009).  This study also reported that within animals, progesterone 
concentrations were similar (i.e., repeatable for cows with low versus high follicle counts) over 3 
estrous cycles.  In addition to impaired luteal function, there is evidence that oocyte quality is 
compromised in cows with low follicular counts.  Ireland et al. (2009) recovered the ovaries 
from cattle with either high or low antral follicle counts on day 2 to 3 of the estrous cycle, and 
recovered the cumulus cells from the 3 largest follicles on each ovary.  Measure of cathepsin B 
and S mRNA in cumulus cells found a 2 and 6 fold increase, respectively, in these mRNA 
transcripts in cumulus cells from animals with low follicle counts.  Both of these mRNA 
transcripts are associated with reduced development of embryos to the blastocyst stage in vitro 
(Bettegowda et al., 2008). 
5 
 
Anti-Mullerian hormone has also been classified as the best predictive marker of the 
ovarian response to a stimulatory treatment, as defined by the number of oocytes collected in 
assisted reproductive technologies (ART) (Muttukrishna et al., 2004; Muttukrishna et al., 2005).  
Muttukrishna et al. (2004) collected blood samples on 69 women who were over the age of 38; 
17 of which were canceled due to poor ovarian response.  Blood samples were collected on day 5 
or 6 of the follicular phase to investigate whether AMH could be a helpful tool in predicting the 
ovarian response to gonadotropin treatment.  The average AMH concentration in blood was 
found to be lower for the canceled group than the completed group.  Therefore, AMH was 
characterized as a predictive marker for the ovarian response in patients undergoing ovarian 
stimulation.  To follow up study Muttukrishna et al. (2005) evaluated the relationship of AMH, 
inhibin B and antral follicle count (AFC) to ovarian response in women undergoing ovarian 
stimulation for in vitro fertilization (IVF).  Ultrasonography was performed on day 3 to 
determine AFC and blood samples were collected for AMH, and inhibin B concentrations.  
Measurements of inhibin B and AFC were found to be positively associated with the number of 
oocytes collected, while AMH was the best predictor of patients who responded poorly to 
superovulatory treatment.  
 In addition to studies in humans, research has been done in livestock species regarding 
the potential use of AMH in assisted reproductive technologies and multiple ovulation and 
embryo transfer (MOET) programs.  Monniaux et al. (2011) conducted an experiment using 
goats to establish any seasonal variation in AMH and AFC (during the breeding season, at the 
end of breeding season, and at the end of anestrus) and determine their effects on embryo 
production.  Plasma was recovered for assay of AMH at three different time periods: before first 
FSH injection (T0), at time of insemination (TI) and at time of embryo collection (TEC) during 
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each season period.  Plasma recovered during the spring (February to April) were found to 
increase in AMH concentration, while plasma recovered in the fall (August to October) slightly 
decreased during the last two weeks.  Anti-Mullerian hormone at (T0) was found to have a high 
positive correlation with the number of embryos collected in all three season periods, with AMH 
expression highest in 1 to 5 mm follicles and expression practically lost in follicles greater than 8 
mm.  The AMH concentration at T0 was found to be a predictive marker for the number of 
embryos recovered, regardless of the season.  While 1 to 5 mm follicles were found to be highly 
correlated with the total number of corpora lutea (CL) and embryos recovered, regardless of the 
season (Monniaux et al., 2011). 
Superovulation and embryo transfer   
 
 The first successful embryo transfer (ET) was reported in 1890, when Walter Heape 
transferred two 4-cell Angora rabbit embryos into a bred Belgian doe that subsequently gave 
birth to four Belgian and two Angora offspring (Heape, 1891).  It was not until 1950 that the first 
live ET calf was produced, by surgical transfer of an in vivo produced embryo recovered at 
slaughter (Willet et al., 1951).  During the mid 1970s, development and/or refinement of non-
surgical embryo collection and transfer techniques led to commercialization of the embryo 
transfer industry.  According to the December 2013 report of the international embryo transfer 
society (IETS) Data Retrieval Committee (http://www.iets.org/comm_data.asp), a total of 
699,586 in vivo derived and 443,533 in vitro derived embryos were produced and available for 
transfer globally in 2013.  
 Over the past 4 decades, numerous research efforts have been directed toward improving 
superovulation regimens in cattle.  Improvement has been made in the porcine FSH product most 
commonly used for superovulation.  For several years, a crude porcine anterior pituitary extract 
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was used which contained varying amounts of both FSH and luteinizing hormone (LH).  
Variation in superovulatory response was attributed to batch-to-batch content of LH (Murphy et 
al., 1984).  A study comparing the superovulatory response with a constant amount of FSH but 
varying amounts of LH reported that the number of fertilized and transferrable embryos 
recovered increased with decreasing LH content (Chupin et al., 1984).  In fact, a later study 
(Looney et al., 1988) reported good superovulatory responses, with a high rate of fertilization 
and viable embryo production, when using recombinant bovine FSH alone (no exogenous LH) 
for superovulation of donor cows.  A study comparing the superovulatory response of FSH 
preparations varying from pure FSH to a 1 to 1 ratio of LH to FSH indicated acceptable 
responses (total, fertilized and transferrable embryo production) occurred when the LH content 
was no more than 15 to 20% (Willmott et al., 1990).  Currently, Follitropin-V is a widely used, 
purified FSH product for superovulation of cows that contains 16% LH.  
 For many years, superovulation was based on the donor's natural estrous cycle, with 
superovulatory treatment initiated between day 8 and 12 of the cycle.  This required that donors 
be successfully synchronized within a few days of each other before superovulation could begin.  
A significant improvement in scheduling of donors occurred with the incorporation of 
supplemental progesterone in the superovulatory regimen.  Goulding et al. (1994) compared the 
superovulatory response of beef heifers where superovulation treatment was initiated mid cycle 
versus after insertion of a progesterone-releasing intravaginal device (PRID) at varying times of 
the cycle.  Results of the study showed that supplemental progesterone could be used to initiate 
superovulation at any stage of the cycle, simplifying scheduling of embryo donors.  To avoid the 
need to synchronize the natural cycle of donors, controlled internal drug release (CIDR) 
progesterone inserts are currently used, with superovulation initiated 7 days after CIDR insertion.   
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 The presence of a dominant follicle at the start of superovulation is known to reduce 
superovulatory response, due to suppression of the stimulatory effects of FSH by inhibin.  This 
inhibition can be avoided by initiation of superovulation at follicular wave emergence.  A 
method of timing initiation of superovulatory treatment with follicular wave emergence is to 
aspirate the 2 largest follicles present on the ovaries (i.e., follicle ablation) and initiate 
superovulatory treatment 2 days later (Baracaldo et al., 2000).  However, this method requires 
transvaginal ultrasound-guided aspiration equipment that most ET practitioners do not have 
access or training to use.  A procedure that has been shown to be as effective as follicle ablation 
is the use of steroid hormones to induce regression of the dominant follicle and emergence of a 
new follicular wave.  With this method, embryo donors receive an injection of estradiol and 
progesterone in conjunction with a CIDR progesterone insert on day 0.  On day 4, superovulation 
is initiated at follicular wave emergence (Baracaldo et al., 2000).  In a superovulation protocol 
where a CIDR is inserted in conjunction with estradiol treatment on day 0 and FSH injections 
started on day 4, Bo et al. (2006) reported that delaying CIDR removal by 12 hours (from day 
6.5 to day 7) and injecting gonadotropin-releasing hormone (GnRH) 12 to 24 hours after CIDR 
removal resulted in both synchronized ovulation and an increase in mean embryo produced.  An 
advantage of the protocol was that it allowed for fixed-time insemination of donors, thus 
eliminating the need to detect estrus.  The use of estradiol alone or in combination and 
progesterone to control follicular wave emergence is very effective.  However, the use of steroids 
is prohibited in many countries.  
While numerous improvements have been made in superovulatory regimens over the 
years, embryo production per donor has shown little progress.  In 1994, members of the 
American Embryo Transfer Association (AETA) reported a mean number of embryos recovered 
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per donor of 5.5.  Twenty years later, AETA and Canadian Embryo Transfer Association 
members reported a range of 5 to 7 embryos recovered per donor (Hasler, 2010).  Donor 
response to gonadotropin treatment remains highly variable between individuals and difficult to 
predict (Rico et al., 2009).  A major source of variability is the status of ovarian follicles at 
initiation of FSH treatment (Rico et al., 2009).  Cows with few growing, small antral follicles 
subsequently have a poor ovulatory response to FSH treatment (Monniaux et al., 1983; 
Kawamata, 1994; Cushman et al., 1999).  Recent studies indicate that AMH could be an 
endocrine marker to help predict superovulatory responses to treatments administered to cows 
for embryo production.   
Monniaux et al. (2010) reported on a study where plasma was collected for measure of 
AMH before the start of superovulation treatment of Holstein cows, to determine if AMH had 
the potential to predict the number of embryos produced by individual cows.  Between cows, 
AMH was found to range from 0.0011 to 0.5312 ng/mL.  Cows with AMH greater than 0.2 
ng/mL produced more embryos than cows having either 0.1 to 0.2 ng/mL or less than 0.1 ng/mL 
of AMH.  In a recent study, Souza et al. (2015) reported that high producing dairy cows with 
AMH concentrations ranging from 0.1844 to 0.3733 ng/mL had a higher superovulatory 
response and more embryos recovered (14 versus 5 to 7) than cows with lower circulating AMH.  
These studies indicate that measure of AMH in blood of potential donor cows would be of value 
in identifying donors more likely to have a good response to superovulation.  Prior knowledge of 
how a potential donor might respond to superovulatory treatment could also allow for 
modification of superovulatory protocols to improve their effectiveness. 
Conclusion  
 After approximately 4 decades of practice, the bovine ET industry is well established in  
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many countries.  Through numerous research efforts, improvements have been made in  
superovulatory products and regimens.  Donor and recipient management have been simplified.   
Despite improvements, extreme donor-to-donor variability in superovulatory response remains a 
concern.  Embryo production per donor has not changed in the past 20 years.  The ability to 
predict superovulatory response and adjust regimens accordingly would be of great benefit to the 
ET industry.  Research indicates that a single measure of circulating AMH accurately reflects the 
population of follicles within the ovaries.  Animals with a greater number of follicles are those 
found to respond well to superovulatory treatments.  Therefore, a study is proposed to investigate 
the use of AMH and/or follicle counts as a predictor of subsequent superovulatory response and 
embryo production in beef cows.  In most instances, the client rather than the ET practitioner 
selects the potential embryo donor.  If either or both AMH and antral follicle counts can 
accurately predict superovulatory responses, then protocols might be adjusted to improve the 
probability of success, regardless of the donor's potential. 
 
 
 
 
 
 
 
11 
 
References  
Baracaldo, M. I., Martinez, M. F., Adams, G. P., & Mapletoft, R. J. (2000). Superovulatory 
 response following transvaginal follicle ablation in cattle. Theriogenology, 53(6), 1239-
 1250.  
Bettegowda, A., Patel, O. V., Lee, K. B., Park, K. E., Salem, M., Yao, J., Ireland, J. J., & Smith,  
G. W. (2008). Identification of novel bovine cumulus cell molecular markers predictive 
of oocyte competence: functional and diagnostic implications. Biology of Reproduction, 
79(2), 301-309. 
 
Bo, G. A., Baruselli, P. S., Chesta, P. M., & Martins, C. M. (2006). The timing of ovulation and  
insemination schedules in superstimulated cattle. Theriogenology, 65(1), 89-101.   
 
Chupin, D., Combarnous, Y., & Procureur, R. (1984). Antagonistic effect of LH in commercially 
 available gonadotrophins. Theriogenology, 25, 229 (abstract). 
 
Cushman, R. A., DeSouza, J. C., Hedgpeth, V. S., & Britt, J. H. (1999). Superovulatory response  
of one ovary is related to the micro-and macroscopic population of follicles in the 
contralateral ovary of the cow. Biology of Reproduction, 60(2), 349-354. 
 
Durlinger, A. L., Kramer, P., Karels, B., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., &  
Themmen, A. P. (1999). Control of Primordial Follicle Recruitment by Anti-Müllerian 
Hormone in the Mouse Ovary 1. Endocrinology, 140(12), 5789-5796. 
 
Erickson, B. H. (1966). Development and senescence of the postnatal bovine ovary. Journal of  
Animal Science, 25(3), 800-805. 
 
Goulding, D., Williams, D. H., Roche, J. F., & Boland, M. P. (1994). Effect of exogenous 
 progesterone on superovulatory response in heifers inseminated with fresh or frozen 
 semen. Journal of Reproduction and Fertility, 100(2), 505-510. 
 
Hasler, J. F. (2010). Bovine Embryo Transfer: Are Efficiencies Improving?. Proceedings  
Applied Reproductive Strategies in Beef Cattle, Nashville, TN. 
 
Heape, W. (1891). Preliminary note on the transplantation and growth of mammalian ova within  
a uterine foster-mother. Proceedings of the Royal Society of London, 48(292-295), 457-
458. 
 
Ireland, J. J., Zielak-Steciwko, A. E., Jimenez-Krassel, F., Folger, J., Bettegowda, A., Scheetz,  
D., Walsh, S., Mossa, F., Knight, P. G., Smith, G. W., Lonergan, P., & Evans, A. C. O. 
(2009). Variation in the ovarian reserve is linked to alterations in intrafollicular estradiol 
production and ovarian biomarkers of follicular differentiation and oocyte quality in 
cattle. Biology of Reproduction, 80(5), 954-964. 
 
 
12 
 
Ireland, J. L. H., Scheetz, D., Jimenez-Krassel, F., Themmen, A. P. N., Ward, F., Lonergan, P.,  
Smith, G. W., Perez, G. I., Evans, A. C. O., & Ireland, J. J. (2008). Antral follicle count 
reliably predicts number of morphologically healthy oocytes and follicles in ovaries of 
young adult cattle. Biology of Reproduction, 79(6), 1219-1225. 
 
Jimenez-Krassel, F., Folger, J. K., Ireland, J. L. H., Smith, G. W., Hou, X., Davis, J. S.,  
Lonergan, P., Evans, A. C. O., & Ireland, J. J. (2009). Evidence that high variation in 
ovarian reserves of healthy young adults has a negative impact on the corpus luteum and 
endometrium during estrous cycles in cattle. Biology of Reproduction, 80(6), 1272-1281. 
 
Josso, N., di Clemente, N., & Gouédard, L. (2001). Anti-Müllerian hormone and its receptors.  
Molecular and Cellular Endocrinology, 179(1), 25-32. 
 
Jost, A., Vigier, B., Prepin, J., & Perchellet, J. P. (1972). Studies on sex differentiation in  
mammals. Recent Progress in Hormone Research, 29, 1-41.  
 
Kawamata, M. (1994). Relationships between the number of small follicles prior to  
superovulatory treatment and superovulatory response in Holstein cows. The Journal of 
Veterinary Medicine Science/the Japanese Society of Veterinary Science, 56(5), 965-967. 
 
La Marca, A., & Volpe, A. (2006). Anti-Müllerian Hormone (AMH) in female reproduction: is  
measurement of circulating AMH a useful tool?. Clinical Endocrinology, 64(6), 603-610. 
 
Looney, C., Bondioli, K., Hill, K., & Massey, J. (1988). Superovulation of donor cows with 
 bovine follicle-stimulating hormone (bFSH) produced by recombinant DNA technology. 
 Theriogenology, 29, 271 (abstract). 
 
Mann, G. E., & Lamming, G. E. (1999). The influence of progesterone during early pregnancy  
in cattle. Reproduction in Domestic Animals, 34(3-4), 269-274. 
 
Monniaux, D., Barbey, S., Rico, C., Fabre, S., Gallard, Y., & Larroque, H. (2010). Anti- 
Müllerian hormone: a predictive marker of embryo production in cattle?. Reproduction, 
Fertility and Development, 22(7), 1083-1091. 
 
Monniaux, D., Baril, G., Laine, A. L., Jarrier, P., Poulin, N., Cognié, J., & Fabre, S. (2011).  
Anti-Müllerian hormone as a predictive endocrine marker for embryo production in the 
goat. Reproduction, 142(6), 845-854. 
 
Monniaux, D., Chupin, D., & Saumande, J. (1983). Superovulatory responses of cattle.  
Theriogenology, 19(1), 55-81. 
 
Munsterberg, A., & Lovell-Badge, R. (1991). Expression of the mouse anti-mullerian hormone  
gene suggests a role in both male and female sexual differentiation. Development, 113(2), 
613-624. 
 
13 
 
Murphy, B. D., Mapletoft, R. J., Manns, J., & Humphrey, W. D. (1984). Variability in 
 gonadotrophin preparations as a factor in the superovulatory response. Theriogenology, 
 21(1), 117-125. 
 
Muttukrishna, S., McGarrigle, H., Wakim, R., Khadum, I., Ranieri, D. M., & Serhal, P. (2005).  
Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian 
response in assisted reproductive technology?. BLOG: An International Journal of 
Obstetrics & Gynaecology, 112(10), 1384-1390. 
 
Muttukrishna, S., Suharjono, H., McGarrigle, H., & Sathanandan, M. (2004). Inhibin B and anti- 
Mullerian hormone: markers of ovarian response in IVF/ICSI patients?. BLOG: An 
International Journal of Obstetrics & Gynaecology, 111(11), 1248-1253. 
 
Perry, P. (2013). 2012 Statistics of embryo collection and transfer in domestic farm animals.  
 IETS Data Retrieval Committee. http://www.iets.org/pdf/comm data/December2013.pdf 
 (accessed December 2013). 
 
Rajpert-De Meyts, E., Jørgensen, N., Graem, N., Müller, J., Cate, R. L., & Skakkebaek, N. E.  
(1999). Expression of Anti-Müllerian Hormone during Normal and Pathological Gonadal 
Development: Association with Differentiation of Sertoli and Granulosa Cells 1. The 
Journal of Clinical Endocrinology & Metabolism, 84(10), 3836-3844.  
 
Rico, C., Fabre, S., Médigue, C., Di Clemente, N., Clément, F., Bontoux, M., Touzé, J. L.,  
Dupont, M., Briant, E., Rémy, B., Beckers, J. F., & Monniaux, D. (2009). Anti-Müllerian 
hormone is an endocrine marker of ovarian gonadotropin-responsive follicles and can 
help to predict superovulatory responses in the cow. Biology of Reproduction, 80(1), 50-
59. 
 
Souza, A. H., Carvalho, P. D., Rozner, A. E., Vieira, L. M., Hackbart, K. S., Bender, R. W.,  
Dresch, A. R., Verstegen, J. P., Shaver, R. D., & Wiltbank, M. C. (2015). Relationship 
between circulating anti-Mullerian hormone (AMH) and superovulatory response of 
high-producing dairy cows. Journal of Dairy Science, 98(1), 169-178.   
 
Teixeira, J., Maheswaran, S., & Donahoe, P. K. (2001). Mullerian inhibiting substance: an  
instructive developmental hormone with diagnostic and possible therapeutic applications. 
Endocrine Reviews, 22(5), 657-674. 
 
Tüttelmann, F., Dykstra, N., Themmen, A. P., Visser, J. A., Nieschlag, E., & Simoni, M. (2009).  
Anti-Müllerian hormone in men with normal and reduced sperm concentration and men 
with maldescended testes. Fertility and Sterility, 91(5), 1812-1819. 
 
Van Rooij, I. A. J., Broekmans, F. J. M., Te Velde, E. R., Fauser, B. C. J. M., Bancsi, L. F. J. M.  
M., De Jong, F. H., & Themmen, A. P. N. (2002). Serum anti-Müllerian hormone levels: 
a novel measure of ovarian reserve. Human Reproduction, 17(12), 3065-3071. 
 
 
14 
 
Visser, J. A., de Jong, F. H., Laven, J. S., & Themmen, A. P. (2006). Anti-Müllerian hormone: a  
new marker for ovarian function. Reproduction, 131(1), 1-9. 
 
Willett, E. L., Black, W. G., Casida, L. E., Stone, W. H., & Buckner, P. J. (1951). Successful  
transplantation of a fertilized bovine ovum. Science (New York, NY), 113(2931), 247. 
 
Willmott, N., Saunders, J., Bo, G. A., Palasz, A., Pierson, R. A., & Mapletoft, R. J. (1990). The 
 effect of FSH/LH ratio in pituitary extracts on superovulatory response in the cow. 
 Theriogenology, 33(1), 347 (abstract). 
 
 
 
 
 
 
  
15 
 
CHAPTER 2: ANTI-MULLERIAN HORMONE AS A PREDICTIVE ENDOCRINE 
MARKER FOR SUPEROVULATORY RESPONSE AND EMBRYO PRODUCTION IN 
BEEF CATTLE 
Abstract 
 A study investigated the use of Anti-Mullerian hormone (AMH) and/or follicle counts as 
a predictor of subsequent superovulatory response and embryo production in 79 beef cows. 
Before initiation of superovulation, ultrasonography was used to scan the ovaries of each donor 
cow to record the number of 3 to 5 mm follicles present, and a blood sample was collected for 
measure of serum AMH.  At the time of embryo collection, the ovaries of donor cows were 
palpated to estimate the number of corpora lutea (CL) present on each ovary.  Recovered 
embryos were evaluated for stage of development and morphological quality.  Across cows, 
serum AMH ranged from 0.013 to 0.898 ng/mL, with a mean of 0.293 ng/mL.  The distribution 
of AMH concentrations was divided into quartiles (AMH Q1 through Q4, with Q1 the lowest 
and Q4 the highest, ng/mL) for analysis.  Donor cows in AMH Q4 had a greater (P < 0.001) 
number of 3 to 5 mm follicles at the start of superovulation than did donors in either Q1 or Q2.  
At embryo collection, cows in AMH Q3 and 4 had more (P < 0.001) palpable CL than cows in 
AMH Q1.  The mean number of embryos recovered from donor cows in AMH Q4 was greater (P 
< 0.001) than those recovered from cows in either AMH Q1 or 2, but similar to that of AMH Q3.  
The percentage of recovered embryos classified as transferrable, degenerate or unfertilized were 
similar (P  0.275) across AMH quartiles.  Analysis indicated that AMH was positively 
correlated (P < 0.001) with mean follicles (r = 0.458), CL (r = 0.452) and embryos recovered (r = 
0.430).  In order to determine if follicle counts at the start of superovulation might also be 
predictive of subsequent superovulatory response, the distribution of follicle counts were divided 
into quartiles (F Q1 through Q4, with Q1 the lowest and Q4 the highest) for analysis.  Donor 
cows with higher follicle counts (F Q3 and 4) at the start of superovulation had more (P < 0.001) 
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palpable CL at embryo collection than donor cows in F Q1 or 2.  More (P < 0.001) embryos were 
recovered from cows with the highest follicle counts (F Q4) as compared with cows having 
lower (F Q1 and 2) follicle counts.  The percentage of transferable embryos and unfertilized ova 
were similar (P  0.688) across follicle count quartiles.  As was noted for AMH, mean number of 
follicles at the start of superovulation was positively correlated (P < 0.001) with mean CL (r = 
0.556) and mean embryos (r = 0.423) but not percentage of viable or degenerate embryos, or 
unfertilized oocytes (P  0.153).  In conclusion, results confirm that relative AMH concentration 
was positively correlated with number of small antral follicles in the ovaries of cows and might 
be used to either predict superovulatory response or possibly adjust superovulatory regimen to 
improve superovulatory response.  Antral follicle counts at the initiation of superovulatory 
treatments might be a more practical alternative to AMH for predicting superovulatory response.  
Further study is needed to determine the effectiveness of using either AMH concentration or 
follicle counts to adjust superovulatory regimens for improved response. 
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Introduction 
Anti-Mullerian hormone (AMH) also known as Mullerian Inhibiting Substance (MIS) is 
a homodimeric disulfide-linked glycoprotein belonging to the transforming growth factor-β 
family, with a molecular weight of 140 kDa (Josso et al., 2001).  In the male, AMH is expressed 
exclusively in the gonads, and causes regression of the Mullerian ducts during male fetal sexual 
differentiation (Jost et al., 1972).  In the female, AMH is expressed within the granulosa cells of 
follicles (Vigier et al., 1984; Takahashi et al., 1986; Monniaux et al., 2008).  Secretion of AMH 
is greatest in 2 to 5 mm follicles but smaller follicles also may contribute to serum AMH 
concentration (Van Rooij et al., 2002).  Expression of AMH decreases as follicles grow and 
enlarge; expression is essentially lost when follicles reach 8 mm diameter or larger (Weenen et 
al., 2004).  
In the ovary, AMH has an inhibitory effect on primordial follicle recruitment as well as 
on the responsiveness of growing follicles to follicle stimulating hormone (FSH) (Visser et al., 
2006).  Anti-Mullerian hormone concentration can be assessed in serum, but the relative 
contribution to the different follicle classes to the final serum concentration is unclear (Van Rooij 
et al., 2002).  A single measurement of AMH concentration in serum is a useful tool to determine 
the size of the ovarian reserve of follicles in cattle (Ireland et al., 2008).  Cattle that have low 
follicle numbers have diminished ovarian function, poor oocyte quality and suboptimal fertility 
(Ireland et al., 2009). 
Anti-Mullerian hormone has also been classified as a good predictive marker of the 
ovarian response to follicular stimulation for oocyte retrieval and in vitro embryo production 
(Muttukrishna et al., 2004; Muttukrishna et al., 2005).  Anti-Mullerian hormone has also been 
classified as an endocrine marker that could help predict superovulatory responses administered 
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to cows for embryo production (Rico et al., 2011).  The present study was conducted to further 
investigate the use of AMH and/or follicle counts as a predictor of subsequent superovulatory 
response and embryo production in beef cows.  
Materials and Methods 
 Animals and Superovulatory Treatments.  A total of 79 cows, including 31 Angus, 2 
Chianina, 10 Polled Hereford, 1 Maine-Anjou, 15 Shorthorn, 3 Simmental, and 17 crossbred of 
various breeds were housed at the Food Animal Veterinary Services donor care facility located in 
Rensselaer, Indiana.  The embryo donors ranged from yearling heifers to 13 year old cows.  
Donor body condition (BCS; 1 to 9 scale; Wagner et al., 1988) ranged from 4 to 8 and averaged 
about 6.  The cows were superovulated for in vivo embryo production, with embryos recovered 
between April 28 and July 10, 2014.  A total of 99 embryo collections were performed, with 20 
of 79 donor cows collected twice.  Depending upon scheduling, client preference and donor 
history, superovulatory treatment was initiated either during the luteal phase of cow's natural 
estrous cycle, or after insertion of a progesterone controlled internal drug release (CIDR) device. 
 Cows that were superovulated based on their natural cycle had superovulatory treatment 
initiated between day 8 and 12 of the estrous cycle.  Cows received twice daily (10 to 12 hours 
apart), decreasing doses of porcine follicle stimulating hormone (FSH; Follitropin-V, Bioniche 
Animal Health, Belleville Ontario CA) over 4-day period.  The cows were injected (i.m) with 50 
mg (NIH units) of FSH twice daily the first 2 days, then 40 and 30 mg twice daily on days 3 and 
4, respectively.  On the morning of the fourth day of FSH treatment, cows received an injection 
of 2.5 cc (~ 312 µg) of Cloprostenol (Estrumate, Merck Animal Health, Summit, NJ) to induce 
luteal regression.  After Cloprostenol treatment, cows were observed for onset of estrus.  
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 Timing of insemination after detected estrus depended on the number of straws and type 
of frozen-thawed semen used.  When a single straw of semen was used, insemination occurred 
12 to 16 hours after detected estrus.  When multiple straws of semen were used, insemination 
occurred within 12 hours of detected estrus, and again 6 to 8 hours later.  When X- or Y-sorted 
semen was used, insemination occurred 16 and again at 24 hours after detected estrus, with 3 to 6 
straws of semen used in total, depending on sperm concentration per straw. 
 Cows superovulated regardless of the day of the estrous cycle, received a 1.38 g 
progesterone insert (EAZI-Breed CIDR; Zoetis, Florham Park, NJ) of day 0, in conjunction with 
an injection (i.m.) of 2.5 mg estradiol 17 beta and 50 mg of progesterone.  On day 4, 
superovulatory treatment was initiated following the same 4-day, descending dose protocol used 
for cows during their natural cycle.  On the morning of the fourth day of FSH treatment, the 
CIDR was removed at the time of Cloprostenol injection.  Insemination of cows after detected 
estrus depended on the type and number of straws of semen to be used, as described previously. 
 Ultrasonography and Blood Collection.  Before the initiation of superovulation, 
ultrasonography (Aloka 500 V with 5.0 MHz linear transducer; Corometrics, Wallingford, CN) 
was used to scan the ovaries of each donor to record the number of 3 to 5 mm follicles present.  
Concurrent with ultrasonography, a 10 mL blood sample was collected via tail vein from each 
cow, using a BD Vacutainer SS Plus Blood Collection Tube, (Ref. No. 367985, Becton, Dickson, 
Franklin Lakes, NJ).  Blood tubes were inverted several times to mix, and then allowed to clot 
for 30 minutes to 1 hour at room temperature.  After clotting, the tubes were held on ice until 
centrifugation at 1,000 g for 10 minutes.  Recovered serum was placed in 5 mL polypropylene 
tubes and stored in a chest freezer at -15 to -20 C until analysis for Anti-Mullerian hormone 
(AMH).   
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 Embryo Recovery and Evaluation.  Non-surgical embryo recoveries were performed ~ 
day 7 of the subsequent estrous cycle, using a Foley catheter and ViGRO complete flush medium 
(ViGRO™, Bioniche Animal Health, Pullman, WA).  At the time of embryo collection, the 
ovaries of donor cows were palpated to estimate the number of corpora lutea (CL) present on 
each ovary.  Recovered flush medium was filtered through a filter to reduce medium volume.  
The flush medium was then searched, using a stereomicroscope to recover embryos.  Recovered 
embryos were evaluated for stage of development (morula, early blastocyst or blastocyst) and 
morphological quality (grade 1, 2, degenerate or unfertilized), using standards established by the 
International Embryo Transfer Society (IETS Manual, 3rd Ed., 1998).  
 Analysis of Serum Anti-Mullerian Hormone.  Serum samples were removed from 
frozen storage and thawed over night at 4 C.  A 500 µL aliquot of serum was removed for each 
tube and pipetted into cryogenic vials (Sumitomo Bakelite, Japan) and then re-frozen (-20 C).  
The serum samples were shipped on dry ice over night to the Texas A&M Veterinary Diagnostic 
Laboratory at College Station, TX.  The diagnostic laboratory used a bovine AMH enzyme-
linked immunosorbent assay kit (Bovine AMH ELISA AL-114; Ansh Labs, Webster, TX) to 
determine AMH concentration (ng/mL) in duplicate samples, following the assay kit 
manufacture’s recommended procedures.  The AMH assay had an analytical sensitivity of 0.011 
ng/mL.   
 Statistical Analysis.  Analysis was performed, using JMP Pro 10.0.0 statistical software 
(SAS Institute, Inc.).  Variables considered in the analysis were embryo donor breed, 
superovulation protocol, AMH concentration, follicle and corpus luteum number, total, 
transferable, degenerate embryos, and unfertilized ova.  Superovulation protocol had no effect (P 
 0.293) on number of corpora lutea, or the number of total, transferrable, degenerate embryos or 
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unfertilized ova, so was removed from the analysis.  There were no breed differences (P = 0.321) 
for serum AMH concentration.  Frequency distribution was used to assign AMH concentration 
measured in serum samples to quartiles.  Analysis of variance was then used to make 
comparisons between AMH quartiles for number of 3 to 5 mm follicles, number of corpora lutea 
at embryo collection, number of embryos recovered, and the percentages of transferrable and 
degenerate embryos, and unfertilized ova.  Percent transferrable embryos were defined as the 
portion of total embryos recovered that were of grade 1 or 2 morphological quality.  Percent 
degenerate embryos were defined as the portion of total embryos recovered that exhibited limited 
cleavage and/or were of poor morphological quality.  Percent unfertilized ova were the portion of 
all recovered embryos/structures that exhibited no cleavage. 
 Frequency distribution was also used to assign follicle counts to quartiles.  Analysis of 
variance was then used to make comparisons between follicle quartiles and number of corpora 
lutea at embryo collection, number of embryos recovered, and the percentages of transferrable 
and degenerate embryos, and unfertilized ova.  Multivariate analysis was used to determine any 
correlations between AMH concentrations and number of 3 to 5 mm follicles, number of corpora 
lutea at embryo collection, number of embryos recovered, and the percentages of transferrable 
and degenerate embryos, and unfertilized ova.  All values are expressed as t h e  mean ± SEM. 
Statistical differences were considered significant where P < 0.05.  
 Superovulation and embryo recovery was performed twice on 20 of 79 donor cows 
included in the study.  To evaluate within donor, the repeatability of AMH, follicle and CL 
counts, and embryos recovered per superovulation, the distribution of the variables were 
assigned to quartiles and compared in a contingency table generated through Chi square analysis. 
Results 
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 Measure of AMH and its predictive value for superovulatory response.  Anti-
Mullerian hormone measured in serum samples ranged from 0.013 to 0.898 ng/mL, with a mean 
of 0.293 ng/mL.  The distribution of AMH concentrations was divided into quartiles (AMH Q1 
through Q4, with Q1 the lowest and Q4 the highest ng/mL) for analysis.  The range of AMH 
concentrations within each quartile are presented in Table 1.  The assay failed to detect AMH in 
3 serum samples, possibly due to either assay failure or concentrations below detection limits.  
Donor cows in AMH Q4 had a greater (P < 0.001) number of 3 to 5 mm follicles at the start of 
superovulation than did donors in either Q1 or Q2.  Cows in AMH Q3 were intermediate for 
mean number of follicles.  At the time of embryo collection, cows in AMH Q3 and 4 had more 
palpable CL than cows in AMH Q1 (P < 0.001).  The mean number of CL for cows in AMH Q2 
was intermediate and similar (P > 0.10) to those in both AMH Q1 and 3.  The mean number of 
embryos recovered for donor cows in AMH Q4 was greater (P < 0.001) than those recovered 
from cows in either AMH Q1 or 2, but similar to that of AMH Q3.  The percentage of recovered 
embryos that were classified as transferrable, degenerate or unfertilized were similar (P  0.275) 
across AMH quartiles.  Multivariate analysis (Table 2) indicated that AMH was positively 
correlated (P < 0.001) with mean follicles (r = 0.458), CL (r = 0.452) and embryos recovered (r = 
0.430).   
 Predictive value of follicle number for superovulatory response.  The number of 3 to 
5 mm follicles counted on the ovaries of donor cows ranged from 5 to over 30, with a mean of 
16.  In order to determine if follicle counts at the start of superovulation might be predictive of 
subsequent superovulatory response, the distribution of follicle counts were also divided into 
quartiles (F Q1 through Q4, with Q1 the lowest and Q4 the highest) for analysis (Table 3).  
Donor cows with higher follicle counts (F Q3 and 4) at the start of superovulation had more (P < 
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0.001) palpable CL at embryo collection than donor cows in F Q1 or 2.  More embryos were 
recovered from cows with the highest follicle counts (F Q4) as compared with cows having 
lower (F Q1 and 2) follicle counts (P < 0.001).  The number of embryos recovered from donors 
in F Q3 was intermediate and similar (P > 0.10) to that of donors in F Q1, 2 and 4.  The 
percentage of transferable embryos and unfertilized ova were similar (P  0.688) across follicle 
count quartiles.  The mean percentage of degenerate embryos was greater for donor cows in F 
Q3 than any other follicle quartile (P = 0.002).  
 As was noted for AMH, mean follicles at the start of superovulation was positively 
correlated (P < 0.001; Table 2) with mean CL (r = 0.556) and mean embryos (r = 0.423) but not 
percentage of viable or degenerate embryos, or unfertilized oocytes (P  0.153).  Other 
correlations noted were positive correlations between mean CL and embryos recovered (r = 
0.887; P < 0.001), and between embryos collected and degenerate embryos (r = 0.236; P = 
0.021).  As might be expected, a significant negative correlation (r = -0.931; P < 0.001) existed 
between percentage viable and percent unfertilized embryos.  
 Repeatability within donors.  Twenty of the donor cows used for the study were 
superovulated and had embryo collections performed twice.  To evaluate repeatability within 
donor, AMH, follicle and CL counts and embryos recovered per collection were assigned to 
quartiles for comparison within donor cows (Table 4).  Only a single serum AMH measure was 
available for one donor.  Of the remaining 19 donors, 17 of 19 were found to be within the same 
or an adjacent quartile for AMH, from one superovulation and embryo collection until the next.  
For follicle counts, 18 of 20 cows were found to fall within the same or an adjacent quartile from 
one collection to the next.  At embryo collection, 16 of 20 donors were within the same or an 
adjacent quartile for CL number, as were 18 of 20 donors for total embryo production.   
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Discussion 
 Since the development of cattle superovulation and non-surgical embryo recovery in the 
1970s, the unpredictability of the superovulatory response has remained a major obstacle.  The 
variability between animals in ovulatory response to FSH-induced superovulation is mainly due 
to differences in ovarian activity at the time of treatment (Rico et al., 2009).  Cows may ovulate 
from 0 to 40 follicles following a 4 to 5 day treatment with FSH (Rouillier et al., 1996).  An 
average response to superovulation is 12 total and 6 transferable embryos, although 15 to 20 
percent of donors will not respond to superovulation (Hasler, 2010).  Cattle that are 
superovulated after reaching age 8 to 10 tend to produce fewer embryos.  Individual variation 
among females remains the largest and least understood variable in superovulation.  While some 
females consistently produce large numbers of embryos, other females of similar age, breed, 
weight, management, and etc. perform poorly.  
 The purpose of superovulation is to stimulate a number of small antral follicles to grow 
and mature, resulting in multiple ovulations.  Therefore, the pool of small antral follicles 
available for stimulation should dictate the superovulatory response.  Previous studies have 
shown a positive correlation between small antral follicle number and serum concentrations of 
AMH (Visser et al., 2006; Ireland et al., 2008).  Furthermore, diminished ovarian reserves of 
follicles have been observed in cattle exhibiting low AMH concentrations (Ireland et al., 2010).  
The present study was conducted to investigate whether AMH and/or antral follicle numbers 
could be used as a predictor of superovulatory response and embryo production in donor cows.   
Assay of AMH in the serum of 79 embryo donor cows in the present study found that 
AMH ranged from 0.013 to 0.898 ng/mL.  Although different ranges have been reported in 
previous years.  Souza et al. (2015) reported an AMH range from 0.00001 to 0.3743 ng/mL, 
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while Monniaux et al. (2010) reported AMH concentrations to range from 0.0011 to 0.5312 
ng/mL and Rico et al. (2009) reported ranges in three different sessions, (T0) first injection of 
FSH, (TE) time of estrus and (TL) 7 days after estrus.  Anti-Mullerian hormone concentrations 
ranged from 0.025 to 0.228 ng/mL at T0, 0.049 to 0.359 ng/mL at TE and 0.026 to 0.212 ng/mL 
at TL, respectively.  Compared to cows with lower AMH, cows with high AMH concentrations in 
serum had the highest follicular counts and ovulatory responses to superovulatory treatment.  
These results agree with data obtained from (Ireland et al., 2008; Rico et al., 2009; Ireland et al., 
2010).  Ireland et al. (2008) reported that AMH concentrations were approximately 6 and 2 fold 
greater in animals with higher follicular counts (39.61 ± 2.3) compared with low follicle counts 
(11.95 ± 1.2).  Rico et al. (2009) indicated that cattle with high numbers of 3 to 7 mm follicles 
before the superovulatory treatment had higher AMH concentrations and resulted in a higher 
ovarian response.  Furthermore, Ireland et al. (2010) classified follicle counts ≥ 3 mm into low (≤ 
15), intermediate (16 to 24) and high (≥ 25) categories.  Anti-Mullerian hormone concentrations 
were found to be 2 and 6 folds higher for cattle within the intermediate or high group.   
A difficulty is using AMH as a predictor of superovulatory response is in how to classify 
a donor cow by AMH.  Studies differ in the reported cut-off values for identifying AMH 
concentration as low, moderate or high.  Rico et al. (2012) reported AMH concentrations ranging 
from 0.005 to 0.244 ng/mL where cattle below 0.087 ng/mL identified as poor responders to 
superovulation and having less than 15 large follicles near the time of estrus.  Guerreiro et al. 
(2014) classified AMH into high and low categories with 0.2 ± 0.01 ng/mL being low and 0.4 ± 
0.02 ng/mL being high.  Ribeiro et al. (2014) classified AMH into three categories, where low 
ranged from 0.01 to 0.14 ng/mL, intermediate 0.141 to 0.45 ng/mL and high 0.451 to 3.19800 
ng/mL.  Differences in cut-off points between studies may be related to several factors, including 
26 
 
differences in measure of superovulatory response (large follicle counts near estrus; Rico et al., 
2012 versus CL counts on the day of embryo collection; Souza et al., 2015), different AMH 
assays, and different methods used to collect plasma as reported by Rico et al. (2012).  
Therefore, cows were classified into quartiles of circulating AMH concentration rather than by 
specific concentrations in blood.  Donor cows within the highest quartile (Q4) for AMH had 
more 3 to 5 mm follicles present in their ovaries at the start of superovulation than did donors in 
the lowest quartile (Q1).  Overall, mean follicle number at the start of superovulatory treatment 
was positively correlated (r = 0.458; P < 0.001) with AMH.  Rico et al. (2009) reported a similar 
correlation (r = 0.79; P < 0.001) between AMH and number of antral follicles detected via 
ultrasonography before the start of superovulatory treatment.  
Donor cows within Q4 for AMH had more CLs and produced more embryos at embryo 
collection than donor cows in the lowest 2 quartiles (Q1 and 2).  As might be expected, mean 
corpora lutea was positively correlated (r = 0.887; P < 0.001) with mean embryos recovered.  
However the number of embryos or structures classified as transferrable, degenerate or 
unfertilized were similar among AMH quartiles and were not correlated with AMH.  Souza et al. 
(2015), who divided superovulated dairy cows into quartiles based on circulating AMH, reported 
results similar to the current study in that total number of embryos recovered was greater for 
donors in the highest AMH quartile versus the lowest.  Also in agreement with the current study, 
Souza et al. (2015) reported that AMH quartile had no effect on the percentage of transferrable 
or fertilized embryos.   
Fertilization rate can vary depending on semen quality and concentration, insemination 
timing and technique, and inherit fertility of the bull.  Embryo morphological quality after 
fertilization can be influenced by the same factors, as well as uterine environment.  Although 
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superovulating cattle does produce more offspring from superior genetics, repeated treatment 
with high doses of gonadotropins can alter follicular development, oocyte maturation, ovulation 
and sperm transport.  These abnormalities may disrupt the normal fertilization and/or embryo 
development process to result in an increased number of unfertilized oocytes and poor quality 
embryos (Kafi and McGowan, 1997).  Perhaps, it is not surprising that level of circulating AMH 
had little measurable effect on fertilization rate or embryo morphological quality.  
Assay for AMH is relatively expensive and limited in availability to most embryo 
transfer practitioners.  However, many practitioners have access to ultrasonography and often 
evaluate ovarian structures before superovulation.  As an alternate to AMH, the number of 3 to 5 
mm follicles present in the ovaries at initiation of superovulatory treatment was evaluated as a 
predictor of superovulatory response.  As with serum AMH, donors were assigned to quartiles 
for comparison.  Results suggest that follicle counts would be of value for predicting subsequent 
superovulatory response.  Donor cows in the highest quartile for 3 to 5 mm follicles also had 
more embryos at collection than cows in the lowest two quartiles.  In a previous study using 
ultrasound to determine antral follicle count, Ireland et al. (2007) reported that cows with high 
follicle numbers also had more embryos recovered and more transferable embryos.   
 As previously stated, there is great donor-to-donor variation in superovulatory response 
and embryo production (Kafi and McGowan, 1997).  Empirical evidence suggests that there is 
more consistency within donors.  A limited number of donors in the present study were 
superovulated and embryo recoveries performed twice.  While AMH concentration varied within 
donor, 17 of 19 donors were categorized within the same or adjacent quartile for AMH prior to 
superovulation.  Likewise follicle counts within donors were within the same or an adjacent 
quartile at subsequent superovulations.  These results confirm that there is some consistency 
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within donors, and that at least over a short (~ 3 month) period of time, a single AMH assay can 
be used as a potential predictor of superovulatory response. 
Currently, embryo donor history such as breed, age, weight, BCS, and parity are used to 
adjust the superovulatory regimen in an effort to improve embryo production.  While 
improvements have been made in hormonal treatment and synchronization protocols (Hasler, 
2014) the mean number of transferrable embryos recovered per donor animal has remained 
relatively constant for the past 40 years.  Many commercial embryo transfer (ET) programs 
across the country are limited in options because donors and service sires are often chosen by the 
owner, and many times procedures are done on farm and mostly out of the control of 
practitioners (Hasler, 2010).  The ability to make adjustments to superovulatory regimens based 
on predicted superovulatory response of individual donors would be of great benefit to the ET 
industry moving forward.  The study confirms that relative AMH level is positively correlated 
with number of small antral follicles in the ovaries of cows and might be used to either predict 
superovulatory response or possibly adjust superovulatory regimen to improve superovulatory 
response.  Antral follicle counts at the initiation of superovulatory treatments might be a more 
practical alternate to AMH for ET practitioners to use in predicting superovulatory response.  
Further study is needed to determine the effectiveness of using either AMH assay or follicle 
counts to adjust superovulatory regimens for improved response. 
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Table 1. Quartile categorization of AMH concentrations as predictor of superovulatory 
outcomes. 
 Quartile of AMH concentration  
Item 
AMH, ng/mL 
Q1 
0.013 - 0.068 
Q2 
0.069 - 0.263 
Q3 
0.264 - 0.363 
Q4 
0.364 - 0.898 
 
P-value 
No. of donors 26 22 24 24  
No. of follicles  13.46 ± 0.91b 14.95 ± 0.98b  16.79 ± 0.94ab 19.33 ± 0.94a  0.001 
No. of CL  11.62 ± 1.54c 13.68 ± 1.67bc 17.58 ± 1.60ab 20.54 ± 1.60a 0.001 
No. of embryos 9.77 ± 1.76b 9.36 ± 1.91b 15.50 ± 1.83ab 20.13 ± 1.83a 0.001 
Transferable %  69.32 ± 6.62 57.06 ± 7.08 58.75 ± 6.62 51.05 ± 6.62 0.275 
Degenerate % 5.52 ± 2.52 7.89 ± 2.69 9.40 ± 2.52 9.87 ± 2.52 0.614 
Unfertilized %  25.16 ± 6.73 35.06 ± 7.19 31.85 ± 6.73 39.09 ± 6.73 0.519 
a,b,c Numbers within rows with unlike superscripts differ (P  0.05). 
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Table 2. Correlations between AMH, follicle counts, and embryo production of             
superovulated donor cows.    
Variable 1 Variable 2 Correlation P-values 
Anti-Mullerian hormone Mean # follicles 0.458 0.001 
 Mean # corpora lutea 0.452 0.001 
 Mean # embryos 0.430 0.001 
 Percent viable -0.126 0.231 
 Percent degenerate 0.195 0.061 
 Percent unfertilized 0.052 0.621 
    
Mean # follicles Mean # corpora lutea 0.556 0.001 
 Mean # embryos 0.423 0.001 
 Percent # viable -0.037 0.724 
 Percent degenerate 0.147 0.153 
 Percent unfertilized -0.018 0.857 
    
Mean # corpora lutea Mean # embryos 0.887 0.001 
 Percent viable -0.008 0.942 
 Percent degenerate 0.191 0.063 
 Percent unfertilized -0.064 0.539 
    
Mean # embryos Percent viable 0.011 0.919 
 Percent degenerate 0.236 0.021 
 Percent unfertilized -0.098 0.341 
    
Percent viable Percent degenerate -0.184 0.073 
 Percent unfertilized -0.931 0.001 
    
Percent unfertilized Percent degenerate -0.188 0.067 
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Table 3. Quartile categorization of follicle counts as a predictor of superovulatory response 
and embryo production. 
 Quartile of follicle counts  
Item Q1 Q2 Q3 Q4 P-value 
  No. of donors 26 35 20 18  
  Follicle range 5 - 12 13 - 17 18 - 20 21 - 30  
No. of CL 10.65 ± 1.40b 13.51 ± 1.20b 19.15 ± 1.59a 23.33 ± 1.68a 0.001 
No. of embryos 9.62 ± 1.79b 11.57 ± 1.55b 16.50 ± 2.04ab 20.00 ± 2.16a 0.001 
Transferable % 58.20 ± 6.44 64.77 ± 5.63 54.51 ± 7.53 58.46 ± 7.97 0.716 
Degenerate % 4.82 ± 2.23b 6.71 ± 1.95b 17.09 ± 2.61a 5.38 ± 2.76b 0.002 
Unfertilized % 36.99 ± 6.44 28.53 ± 5.63 28.39 ± 7.54 36.16 ± 7.97 0.688 
a,b Numbers within rows with unlike superscripts differ (P  0.05). 
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Table 4.  Repeatability of embryo donors for AMH, follicle and corpus luteum counts and 
embryo production. 
 Superovulation and 
embryo collection  
Superovulation and 
embryo collection 
Superovulation and 
embryo collection 
Superovulation and 
embryo collection 
 1 2 1 2 1 2 1 2 
Embryo 
Donor 
AMH 
quartile 
AMH 
quartile 
Follicle 
quartile 
Follicle 
quartile 
CL 
quartile 
CL  
quartile 
Embryo 
quartile 
Embryo 
quartile 
1 1 1 1 2 1 2 3 3 
2 3 4 2 3 2 3 3 4 
3 3 4 2 3 2 2 2 2 
4 4 4 2 3 2 3 3 3 
5 3 4 1 2 1 2 1 2 
6 1 1 1 2 1 1 1 1 
7 1 3 2 3 3 3 3 4 
8 1 3 2 3 1 2 1 2 
9 4 4 4 4 4 4 4 4 
10 * 2 2 3 2 2 1 2 
11 1 1 2 2 1 1 1 1 
12 3 4 3 3 2 4 3 4 
13 1 1 1 2 1 2 2 2 
14 2 2 1 2 1 2 1 1 
15 3 4 3 4 3 4 2 4 
16 3 4 1 4 4 4 3 4 
17 3 4 4 4 4 4 4 4 
18 2 2 3 4 1 4 1 1 
19 1 2 1 1 1 3 1 3 
20 1 1 2 4 2 4 3 3 
*Anti-Mullerian hormone could not be detected in one blood sample from donor 10. 
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CHAPTER 3: CONCLUSION 
 
Research presented in this thesis examined physiological variations and clinical 
applications of Anti-Mullerian hormone (AMH) in various breeds of cattle.  In addition, antral 
follicle counts (AFC) were evaluated via ultrasonography to evaluate the correlation among 
AMH, AFC, total number of corpora lutea (CL), total number of embryos recovered in vivo, and 
the percentage of unfertilized oocytes.  The primary goal of this review was to focus on AMH 
expression in the cow; nevertheless, some of the derived information in this document was 
accommodated from other species but not limited to humans, goats and rodents.     
Anti-Mullerian hormone is one of the most important hormones in reproductive 
physiology because of the role the hormone plays in sexual differentiation during fetal 
development.  To date, AMH has been compared to AFC which represents the total number of 
follicles detected using ultrasonography although, is it possible a large proportion of atretic 
follicles, do not contribute to circulating AMH concentrations.  Therefore, one could theorize 
that AMH concentrations are a reflection on the number of follicles being recruited in each 
follicular wave, although it would be difficult to detect as new recruited follicles are being 
overlapped by larger regressing follicles.  Nevertheless, AMH appeared to be a useful tool on the 
prediction of total number of antral follicles and embryos in the cow.  
The variation in AMH concentration and AFC in cows tended to reflect ovarian reserve 
and follicular function.  Results in this study indicated that follicle and embryo numbers are 
impaired with low AFC or low AMH concentration and that higher AFC and AMH resulted in 
higher follicle and embryo numbers, respectively.  Therefore, measuring the concentration of 
AMH as well as determining the number of antral follicles should be an essential part in the 
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reproductive examination of cattle as it provides valuable information about superovulatory 
response and could help embryo transfer practitioners predict how well a cow will respond to 
superovulatory treatments throughout her reproductive lifespan.  
In conclusion, circulating AMH concentration and AFC were highly associated with 
superovulatory response and the total number of embryos produced in individual cows.  If 
commercial AMH assays were to become available it could become a valuable practical method 
for improving the efficiency of multiple ovulation and embryo transfer (MOET) programs in 
beef cattle herds not only in America but across the world.  
   
 
 
